Kardiovaskulyarnoe «bremya» Ozhireniyai Profilakticheskie vozmozhnostiKsenikala (Orlistat 120 Mg)

Obesity and Metabolism - Russian Federation
doi 10.14341/2071-8713-5205
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Endocrinology Research Centre

Related search

Orlistat and L-Carnitine Compared to Orlistat Alone on Insulin Resistance in Obese Diabetic Patients

Endocrine Journal
EndocrinologyMetabolismDiabetes
2010English

Response to Regorafenib at an Initial Dose of 120 Mg as Salvage Therapy for Metastatic Colorectal Cancer

Molecular and Clinical Oncology
Cancer ResearchOncology
2017English

Editorial - Over-The-Counter Orlistat

Hospital Pharmacy
PharmacologyPharmacy
2006English

Survival Benefit of Intravenous Busulfan (120 Mg/M2) and Fludarabine Myeloablative Regimen for Treatment of Myeloid Malignancies

Journal of Stem Cell Research & Therapy
2016English

Glucose and Lipid Levels With Lanreotide Autogel 120 Mg in Treatment-Naïve Patients With Acromegaly: Data From the PRIMARYS Study

Clinical Endocrinology
EndocrinologyMetabolismDiabetes
2016English

Orlistat-Induced Gut Microbiota Modification in Obese Mice

Evidence-based Complementary and Alternative Medicine
Alternative MedicineComplementary
2020English

Influence of Orlistat on Bone Turnover and Body Composition

International Journal of Obesity
NutritionEndocrinologyDieteticsMedicineMetabolismDiabetes
2001English

Numéro 120 - Novembre 2015

Regards économiques
2018English

LanroNET — Nieinterwencyjne Badanie Prospektywne Oceniające Wykorzystanie Zasobów Medycznych I Koszty Lanreotide Autogel 120 Mg W Populacji Polskich Pacjentów Z Objawowymi Guzami Neuroendokrynnymi

Endokrynologia Polska
EndocrinologyMetabolismDiabetes
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy